Biological markers of hepatocellular carcinoma
Arfaoui, D.; Elloumi, H.; Ajmi, S.
La Tunisie Medicale 82(4): 329-334
2004
ISSN/ISBN: 0041-4131 PMID: 15453027 Document Number: 580541
Hepatocellular carcinoma is a rapidly fatal tumor. The only hope for a cure lies in early diagnosis. It follows that an effective screening strategy should be used in high-risk populations. Screening currently relies on tumor markers such as alfa fetoprotein (AFP) and imaging modalities. Because the AFP assay lacks sensitivity and specificity in patient with small tumors, other serum markers are being evaluated.
Document emailed within 1 workday
Related Documents
Kubo, S.; Matsukawa, M. 2004: Tumor markers of hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(13): 2203-2206Blum, H.E. 2001: Hepatocellular carcinoma: susceptibility markers Iarc Scientific Publications 154: 241-244
Yao, D.-F.; Dong, Z.-Z.; Yao, M. 2007: Specific molecular markers in hepatocellular carcinoma Hepatobiliary and Pancreatic Diseases International: Hbpd Int 6(3): 241-247
Ebelt, J.; Neid, M.; Tannapfel, A.; Witzigmann, H.; Hauss, J.; Köckerling, F.; Wittekind, C. 2000: Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC) Zentralblatt für Chirurgie 125(7): 597-601
de Oliveira e Silva, A.; Roldan-Molina, F.; dos Santos, T.E.; Santo, G.C.; Miranda, M.P.; Genzini, T.; Neves, L.B.; D'Albuquerque, L.A. 1990: Diagnosis of hepatocellular carcinoma performed by searching for serologic tumor markers Arquivos de Gastroenterologia 27(2): 83-94
Khin, L.W.; Teo, C.J.; Guan, R. 1996: Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore Singapore Medical Journal 37(5): 492-496
Nakagawa, M.; Asahina, Y. 2015: Prognostic significance of fibrosis markers in hepatocellular carcinoma among patients with IFN-based therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 668-673
Dong, H.; Cong, W.-L.; Zhu, Z.-Z.; Wang, B.; Xian, Z.-H.; Yu, H. 2008: Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma Zhonghua Zhong Liu Za Zhi 30(9): 702-705
Gafton, B.; Porumb, V.; Ungurianu, S.; Marinca, M.V.; Cocea, C.; Croitoru, A.; Balan, G.; Miron, N.; Eliade Ciuleanu, T.; Miron, L. 2014: Hepatocellular carcinoma: insights in the biological treatment beyond sorafenib Journal of Buon: Official Journal of the Balkan Union of Oncology 19(4): 858-866
Cong, W.M.; Wu, M.C. 1989: Small hepatocellular carcinoma. DNA content and biological characteristics Chinese Medical Journal 102(10): 783-785
Ruck, P.; Xiao, J.C.; Kaiserling, E. 1995: Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34 Archives of Pathology and Laboratory Medicine 119(2): 173-178
Peng, J.; Cai, S.; Leng, X.; Mu, D.; Lu, J.; Chen, H.; Rui, J. 2002: MRNA of MAGE genes as specific markers in detection of tumor cells in the peripheral blood of patients with hepatocellular carcinoma Zhonghua Yu Fang Yi Xue Za Zhi 36(7): 487-490
Avalos, E.; Martín, A.; Porras, E.; Martínez, E.; Araújo, J.; Córdoba, J.; Carrillo de Albornoz, F. 1998: Biological markers of alcohol abuse in patients with carcinoma of the larynx Acta Otorrinolaringologica Espanola 49(6): 465-466
Antón Aranda, E.; Martí Cabané, J.; Tiberio López, G.; Pérez Garciá, C. 1984: Colorectal carcinoma. Diagnostic value of various biological markers in postoperative recurrences Revista Clinica Espanola 172(2): 69-73
Kapp, P.; Bély, M.; Nemesánszky, E.; Szende, B. 2001: The role of perisinusoidal (Ito) cells in the course of hepatocellular carcinoma: light and electron microscopic data to the pathogenesis of hepatocellular carcinoma Orvosi Hetilap 142(49): 2741-2746
Nagao, T.; Ishida, Y.; Kondo, Y. 1996: Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histologic grade and other cell proliferative markers Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 9(2): 99-104
Zenali, M.J.; Tan, D.; Li, W.; Dhingra, S.; Brown, R.E. 2010: Stemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma Annals of Clinical and Laboratory Science 40(2): 126-134
Akahane, Y. 2001: Hepatocellular carcinoma in patients with parasitic liver disease--Japanese schistosomiasis and hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 474-477
Tabarin, A.; Bioulac-Sage, P.; Boussarie, L.; Balabaud, C.; de Mascarel, A.; Grimaud, J.A. 1987: Hepatocellular carcinoma developed on noncirrhotic livers. Sinusoids in hepatocellular carcinoma Archives of Pathology and Laboratory Medicine 111(2): 174-180
Yamauchi, M.; Yoshigoe, F.; Mera, F.; Ogura, K.; Kameda, H.; Nakada, J.; Takasaka, S.; Machida, T.; Fukunaga, M. 1983: An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers Gan no Rinsho. Japan Journal of Cancer Clinics 29(4): a